⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29089182 | 1.00 | — | — | |
| SCHEMBL291974 | 1.00 | — | — | |
| SCHEMBL1085453 | 0.97 | — | — | |
| SCHEMBL28277812 | 0.97 | — | — | |
| SCHEMBL5677161 | 0.97 | — | — | |
| SCHEMBL157628 | 0.78 | — | — | |
| SCHEMBL866414 | 0.78 | SLC7A5 (0.36) | — | |
| SCHEMBL6536106 | 0.78 | SLC7A5 (0.36) | — | |
| SCHEMBL17222464 | 0.78 | SLC7A5 (0.36) | — | |
| SCHEMBL2027762 | 0.78 | SLC7A5 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230313218-A1 | ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, CONSTRUCT AND PLANTS COMPRISING SAME AND METHODS OF USING SAME FOR INCREASING NITROGEN USE EFFICIENCY OF PLANTS | EVOGENE LTD. (IL) | 2023-10-05 | — | — | US | disclosed |
| US-20230167160-A1 | ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, AND METHODS OF USING SAME FOR INCREASING PLANT YIELD AND/OR AGRICULTURAL CHARACTERISTICS | EVOGENE LTD. (IL) | 2023-06-01 | — | — | US | disclosed |
| US-20230140118-A1 | ISOLATED POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS OF USING SAME FOR INCREASING ABIOTIC STRESS TOLERANCE, BIOMASS AND YIELD OF PLANTS | EVOGENE LTD. (IL) | 2023-05-04 | — | — | US | disclosed |
| US-20230109864-A1 | ISOLATED POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS OF USING SAME FOR INCREASING ABIOTIC STRESS TOLERANCE, BIOMASS AND YIELD OF PLANTS | EVOGENE LTD. (IL) | 2023-04-13 | — | — | US | disclosed |
| US-20230110335-A1 | ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, AND METHODS OF USING SAME FOR INCREASING PLANT YIELD AND/OR AGRICULTURAL CHARACTERISTICS | EVOGENE LTD. (IL) | 2023-04-13 | — | — | US | disclosed |
| US-20230073242-A1 | ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, AND METHODS OF USING SAME FOR INCREASING NITROGEN USE EFFICIENCY OF PLANTS | EVOGENE LTD. (IL) | 2023-03-09 | — | — | US | disclosed |
| US-20230047441-A1 | ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, AND METHODS OF USING SAME FOR INCREASING YIELD OF PLANTS | EVOGENE LTD. (IL) | 2023-02-16 | — | — | US | disclosed |
| US-11566053-B2 | Plant traits conferred by isolated polynucleotides and polypeptides | EVOGENE LTD. (IL) | 2023-01-31 | — | — | US | disclosed |
| US-11560573-B2 | Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics | EVOGENE LTD. (IL) | 2023-01-24 | — | — | US | disclosed |
| US-20230019445-A1 | ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, AND METHODS OF USING SAME FOR INCREASING NITROGEN USE EFFICIENCY, YIELD, GROWTH RATE, VIGOR, BIOMASS, OIL CONTENT, AND/OR ABIOTIC STRESS TOLERANCE | EVOGENE LTD. (IL) | 2023-01-19 | — | — | US | disclosed |
| US-20080200725-A1 | Enhanced bioavailability; reacting fatty acid and amino acid using thionyl halide | 2462096 ONTARIO LIMITED (CA) | 2008-08-21 | — | — | US | disclosed |
| EP-1881020-A1 | POLYMERIC DERIVATIVE OF CYTIDINE METABOLIC ANTAGONIST | Nippon Kayaku Kabushiki Kaisha (JP) | 2008-01-23 | — | — | EP | disclosed |
| CN-1824640-A | Method for preparing hydroxyalkyl acrylate using lewis acid catalyst | BAYER MATERIALSCIENCE AG (DE) | 2006-08-30 | — | — | CN | disclosed |
| US-6552079-B2 | Integrin antagonists | ELI LILLY AND COMPANY | 2003-04-22 | — | — | US | disclosed |
| EP-0963370-B1 | INTEGRIN ANTAGONISTS | LILLY CO ELI (US) | 2003-03-19 | — | — | EP | disclosed |
| US-20010034369-A1 | Integrin antagonists | SCARBOROUGH ROBERT M (US) | 2001-10-25 | — | — | US | disclosed |
| US-6245809-B1 | THERAPY FOR THROMBOSIS, RESTENOSIS | COR THERAPEUTICS INC. | 2001-06-12 | — | — | US | disclosed |
| EP-0963370-A1 | INTEGRIN ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1999-12-15 | — | — | EP | disclosed |
| WO-1998025892-A1 | INTEGRIN ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1998-06-18 | — | — | WO | disclosed |
| EP-0207655-B1 | DEHYDRATED, DEFLATED CAPSULES AND METHODS OF PRODUCING SUSTAINED RELEASE COMPOSITIONS | DAMON BIOTECH, INC. (US) | 1989-09-27 | — | — | EP | disclosed |